Analgesia in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Aortic Valve Stenosis
Interventions
PROCEDURE

Nerve block

drug mixture: 10-15 ml 0.5% ropivacaine plus 5 ml 1% lidocaine plus 1 mg dexamethasone plus 50 ug adrenaline

PROCEDURE

Local infiltration

15-20 ml of mixture of 0.5% bupivacaine and 1% lidocaine (1:1)

PROCEDURE

TAVI

Insertion of an aortic valve prothesis through the aorta accessed through femoral artery

DRUG

Additional intraoperative analgesia

Administration of any analgesics during the operation

DRUG

Additional postoperative analgesia

Administration of any analgesics within first 24 hours after the operation

Trial Locations (1)

80-211

University Clinical Centre, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT03863899 - Analgesia in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI) | Biotech Hunter | Biotech Hunter